Vaccines Protect Against Infection from Omicron Subvariant–But Not for Long
March 22, 2022
(Nature) – The Omicron subvariant BA.2 is replacing its sister version, BA.1, as the dominant form of SARS-CoV-2 in many countries, which has led scientists to wonder whether the COVID-19 pandemic is about to throw these regions into disarray yet again. But a study published on 13 March shows that mRNA vaccines offer a similar degree of protection against the two strains — although protection against SARS-CoV-2 infection and symptomatic disease wanes within months of a third dose. The study, published on the preprint server medRxiv, has not yet been peer reviewed. (Read More)